Veerhealth Care Intrinsic Value
Veerhealth Care (VEERHEALTH) median intrinsic value is ₹20.00 from 9 valuation models (range ₹15–₹53), vs current price ₹49.99 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit VEERHEALTH stock price BSE.
VEERHEALTH Valuation Methods Summary — DCF, Graham Number & P/E
Veerhealth Care intrinsic value across 9 models vs current price ₹49.99 — upside/downside and value range per method. Check VEERHEALTH market cap trends to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹17.60 | ₹14.08 - ₹21.12 | -64.8% | EPS: ₹0.80, Sector P/E: 22x |
| Book Value Method | asset | ₹23.00 | ₹20.70 - ₹25.30 | -54.0% | Book Value/Share: ₹11.50, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹53.00 | ₹47.70 - ₹58.30 | +6.0% | Revenue/Share: ₹26.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹20.00 | ₹18.00 - ₹22.00 | -60.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹27.17 | ₹21.74 - ₹32.60 | -45.6% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹15.00 | ₹13.50 - ₹16.50 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹15.00 | ₹13.50 - ₹16.50 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹25.00 | ₹22.50 - ₹27.50 | -50.0% | ROE: 8.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹15.00 | ₹13.50 - ₹16.50 | -70.0% | EPS: ₹0.80, BVPS: ₹11.50 |
VEERHEALTH Intrinsic Value vs Market Price — All Valuation Models
Veerhealth Care fair value range ₹15–₹53 vs current market price ₹49.99 across 9 valuation models. See Veerhealth Care P/B ratio trends to compare market price against book value per share.
VEERHEALTH Intrinsic Value Analysis — Undervalued or Overvalued?
Veerhealth Care median intrinsic value ₹20.00, current price ₹49.99 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of VEERHEALTH?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Veerhealth Care (VEERHEALTH) is ₹20.00 (median value). With the current market price of ₹49.99, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹15.00 to ₹53.00, indicating ₹15.00 - ₹53.00.
Is VEERHEALTH undervalued or overvalued?
Based on our multi-method analysis, Veerhealth Care (VEERHEALTH) appears to be trading above calculated value by approximately 60.0%.
VEERHEALTH Financial Health — Key Ratios vs Industry Benchmarks
Veerhealth Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.38 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 10.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.20x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
VEERHEALTH Cash Flow Quality — Operating & Free Cash Flow
Veerhealth Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹4 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹5 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |